Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Nav

General Info

Geography

United States of America (USA)

Time period covered

01/1993 - 12/2001

Data type

Scientific literature

Keywords

Multiple myeloma, Body mass index

Citation

Authors

Moore LE, Pfeiffer RM, Zhang Z, Lu KH, Fung ET, Bast RC

Journal

Cancer

Volume

118

Issue

Pages

91–100

Publication year

2012

Suggested citation

Moore LE, Pfeiffer RM, Zhang Z, Lu KH, Fung ET, Bast RC. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer. 2012; 118(1): 91–100.

GHDx Entry last modified on: Jul 20, 2021

Header sites

Search form

Main menu

Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Nav